| Literature DB >> 29123080 |
Naoki Yoneda1, Yuki Fujii1, Akira Matsumoto1, Keisuke Asano2, Seijiro Matsubara3.
Abstract
Enantioselective approaches to synthesize six-membered oxacycles with multiple stereogenic centres are in high demand to enable the discovery of new therapeutic agents. Here we present a concise organocatalytic cycloetherification for the highly enantio- and diastereoselective synthesis of tetrahydropyrans involving simultaneous construction of two chiral centres, one of which is fully substituted. This method involves dynamic kinetic resolution of reversibly generated chiral cyanohydrins. A chiral bifunctional organocatalyst selectively recognizes a specific chair-like conformation of the intermediate, in which the small steric effect of the linear cyano group as well as its anomeric effect play important roles in controlling stereoselectivity. The products offer additional utility as synthetic intermediates because the cyano group can be further transformed into a variety of important functional groups. This strategy provides a platform to design efficient approaches to obtain a wide range of optically active tetrahydropyrans, which are otherwise synthetically challenging materials.Entities:
Year: 2017 PMID: 29123080 PMCID: PMC5680189 DOI: 10.1038/s41467-017-01099-x
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Fig. 1Simultaneous construction of two stereogenic centres in tetrahydropyrans. a Cycloetherification via kinetic resolution of racemic alcohols. b Cycloetherification via dynamic kinetic resolution involving reversible addition of a carbon nucleophile to ketones
Fig. 2Reaction design for cycloetherification via dynamic kinetic resolution. a Intramolecular oxy-Michael addition via dynamic kinetic resolution through reversible generation of chiral cyanohydrins. b Rationale for the proposed strategy
Optimization of reaction conditions
|
| |||||
|---|---|---|---|---|---|
| Entry | Catalyst | Solvent | Yield (%) | dr | ee (%) |
| 1 |
| CH2Cl2 | 99 | > 20:1 | 97 |
| 2 |
| CH2Cl2 | 95 | 14:1 | –97 |
| 3 |
| CH2Cl2 | < 1 | — | — |
| 4 |
| CH2Cl2 | 89 | 14:1 | –92 |
| 5 |
| CH2Cl2 | 69 | 17:1 | –94 |
| 6 |
| CH2Cl2 | 72 | 11:1 | 93 |
| 7 |
| CH2Cl2 | 82 | 10:1 | 94 |
| 8a |
| CH2Cl2 | 84 | > 20:1 | 97 |
| 9b |
| CH2Cl2 | 14 | > 20:1 | 97 |
| 10 |
| CHCl3 | 93 | > 20:1 | 97 |
| 11 |
| Benzene | 93 | > 20:1 | 95 |
| 12 |
| Toluene | 90 | > 20:1 | 95 |
| 13 |
| Et2O | 59 | 20:1 | 93 |
| 14 |
| THF | 15 | 20:1 | 96 |
| 15 |
| EtOAc | 38 | 17:1 | 94 |
| 16 |
| CH3CN | 54 | 3.6:1 | 95 (93d) |
| 17 |
| EtOH | 23 | 9.2:1 | 96 (88d) |
| 18c |
| CH2Cl2 | 84 | > 20:1 | 96 |
Reactions were run using 1a (0.15 mmol), 2 (0.30 mmol), catalyst (0.015 mmol), and solvent (0.30 ml). Yields represent material isolated after silica gel column chromatography. Diastereomeric ratios (dr) were determined by 1H NMR spectroscopy
aReaction was run using trimethylsilyl cyanide (0.30 mmol) with 2-propanol (0.30 mmol) instead of 2
bReaction was run using trimethylsilyl cyanide (0.30 mmol) instead of 2
cReaction was run using 0.18 mmol of 2 and 0.0075 mmol of 4a for 48 h
dValues are for minor diastereomers
Fig. 3Substrate scope. Reactions were run using 1 (0.15 mmol), 2 (0.30 mmol), and 4a (0.015 mmol) in CH2Cl2 (0.30 ml). Yields represent material isolated after silica gel column chromatography. Diastereomeric ratios (dr) were determined by 1H NMR spectroscopy. *Reaction was run for 72 h
Fig. 4Cyanohydrin formation under the optimized conditions. Reactions were run using 5 (0.15 mmol), 2 or trimethylsilylcyanide (0.30 mmol), and 4a (0.015 mmol) in CH2Cl2 (0.30 ml)
Fig. 5Transformations of the cyano group in product 3a. Synthesis of 8: 3a (0.10 mmol) was treated with lithium aluminium hydride (0.50 mmol) in Et2O (1.0 ml). Synthesis of 9: 8 (0.10 mmol) was treated with manganese dioxide (1.0 mmol) in CH2Cl2 (2.0 ml). Synthesis of 10: 3a (0.10 mmol) was treated with diisobutylaluminium hydride (0.40 mmol) in CH2Cl2 (1.0 ml). Synthesis of 11: 10 (0.056 mmol) was treated with pyridinium chlorochromate (0.17 mmol) in CH2Cl2 (2.0 ml)